MediGene AG (MDGEF)
0.10
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
MediGene Shareholders Equity (Quarterly)
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | 91.85M |
| September 30, 2019 | 93.51M |
| June 30, 2019 | 103.89M |
| March 31, 2019 | 114.70M |
| December 31, 2018 | 118.03M |
| September 30, 2018 | 121.89M |
| June 30, 2018 | 127.72M |
| March 31, 2018 | 101.84M |
| December 31, 2017 | 103.47M |
| September 30, 2017 | 105.29M |
| June 30, 2017 | 103.06M |
| March 31, 2017 | 80.19M |
| December 31, 2016 | 82.89M |
| September 30, 2016 | 92.21M |
| June 30, 2016 | 97.29M |
| March 31, 2016 | 100.41M |
| December 31, 2015 | 97.75M |
| September 30, 2015 | 102.44M |
| June 30, 2015 | 59.38M |
| March 31, 2015 | 49.25M |
| December 31, 2014 | 59.38M |
| September 30, 2014 | 62.44M |
| June 30, 2014 | 51.18M |
| March 31, 2014 | 52.37M |
| December 31, 2013 | 49.99M |
| Date | Value |
|---|---|
| September 30, 2013 | 52.62M |
| June 30, 2013 | 53.28M |
| March 31, 2013 | 52.65M |
| December 31, 2012 | 58.29M |
| September 30, 2012 | 58.57M |
| June 30, 2012 | 60.91M |
| March 31, 2012 | 60.73M |
| December 31, 2011 | 62.22M |
| September 30, 2011 | 73.71M |
| June 30, 2011 | 79.26M |
| March 31, 2011 | 81.32M |
| September 30, 2010 | 67.98M |
| June 30, 2010 | 68.18M |
| March 31, 2010 | 69.76M |
| December 31, 2009 | 74.42M |
| September 30, 2009 | 75.23M |
| June 30, 2009 | 85.61M |
| March 31, 2009 | 85.57M |
| December 31, 2008 | 90.22M |
| September 30, 2008 | 106.81M |
| June 30, 2008 | 133.16M |
| March 31, 2008 | 144.92M |
| December 31, 2007 | 150.73M |
| September 30, 2007 | 163.17M |
| June 30, 2007 | 146.11M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| InflaRx NV | 167.13M |
| BioNTech SE | 20.30B |
| Immatics NV | 456.89M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |